Skip to content

OCRA Corporate Sponsors & Partners

Corporate Sponsors

We are deeply grateful to our past and current corporate partners for supporting our mission to find a cure and improve the lives of those affected by ovarian and other gynecologic cancers.

Corporate Partners

Conflict of Interest Statement — Industry Partners

  • Corporate partners including industry do not shape OCRA’s agenda, research, or advocacy.
  • In 2023, industry partners represented 8% of OCRA’s overall revenue.
  • If an industry partner sponsors an OCRA program, grant, or educational materials, it is publicly acknowledged and the supporting company has no editorial or strategic input.
  • Any reference to a specific commercial product or service does not constitute or imply an endorsement by OCRA of the product or service or its producer or provider. The views and opinions expressed in any referenced document or on any referenced website do not necessarily reflect those of OCRA.

Related Topics

The Overview: July 2025

The Overview: July 2025

OCRA Rivkin Family SummeRun Raises Over $320,000 for Research More than 900 participants gathered at Seattle’s Seward Park for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, raising more than … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.